前言目的观察蒿甲醚胶囊治疗多形性日光疹（polymorphouslighteruption,PLE）和慢性光化性皮炎（chronicactinicdermatitis,CAD）的临床疗效及安全性,为光敏性皮肤病寻找更好的治疗方法.方法105例慢性光化性皮炎和63例多形性日光疹病人随机分为治疗组和对照组,治疗组（CAD63例,PLE32例）口服蒿甲醚胶囊,40mg/次,2次/d;对照组口服硫酸羟氯喹片（CAD42例,PLE31例）0.2g/次,2次/d.局部均用10%氧化锌软膏外檫2次/d,其它治疗相同,半月1疗程,治疗两疗程.结果多形性日光疹治疗组总有效率84.4%（27/32）,对照组总有效率80.6%（25/31）,两组总有效率经卡方检验统计无显著性差异.慢性光化性皮炎治疗组总有效率85.7%（54/63）,对照组81%（34/42）,两组总有效率经卡方检验统计无显著性差异.口服蒿甲醚胶囊治疗多形性日光疹和慢性光化性皮炎均未发现副作用.结论蒿甲醚胶囊治疗多形性日光疹和慢性光化性皮炎是有效、安全、方便、经济的.
ObjectiveToobservetheclinicaleffectandsafetyofpolymorphouslighteruption（PLE）andthoseofchronicactinicdermatitis（CAD）treatedwithArtemtherin.Tofurtherstudybettertreatmentmethodsforphotodermatitis.Methods105patientswithCADand63patientswithPLEweredividedintothetreatmentgroupandthecontrolgrouprandomly.Inthetreatmentgroup,63casesofCADand32casesofPLEweretreatedwithArtemtherin.Inthecontrolgroup,42casesofCADand31casesofPLEtreatedwithHydroxych...
